Recombinant CD47 (Magrolimab Biosimilar) antibody

Catalog No. ABIN7488214

This Mammalian Cells Monoclonal antibody specifically detects CD47 (Magrolimab Biosimilar) in ELISA. It exhibits reactivity toward Human.

Quick Overview for Recombinant CD47 (Magrolimab Biosimilar) antibody (ABIN7488214)

Target: CD47 (Magrolimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This CD47 (Magrolimab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-CD47 (Magrolimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Magrolimab Biosimilar - Anti-CD47 mAb

Characteristics: Antibody Type: IgG4-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for CD47 (Magrolimab Biosimilar)

Target: CD47 (Magrolimab Biosimilar)

Target Type: Biosimilar

Background: Hu5F9-G4
Magrolimab (Hu5F9-G4) is a first-in-class humanized anti-CD47 IgG4 antibody with an anti-tumor activity.

CAS-No: 2169232-81-7